Global Gallbladder Treatment Market Is Expected To Reach USD 28,563.7 Million By 2030

Pune, India, 2022 /MRFR Press Release/- Market Research Future has a cooked research report on global gall bladder treatment market.

Gallbladder Treatment Market Highlights

Gall bladder diseases affect a large number of people in the world. Approximately, 10–15% of adults in developed countries are suffering form gallstones. Gallbladder and biliary related diseases occurred in about 104 million people (1.6%) in 2013. The gall bladder diseases are treated by surgeries or by drugs. Number of different types of surgeries are available in the market, however, open cholecystectomy was formerly the gold standard of treatment for gallstones, until the advent of laparoscopic cholecystectomy and other minimal invasive and non-invasive treatment.

The global gall bladder treatment market is driven majorly by increasing number of people suffering from gall bladder diseases, development of minimally invasive surgery techniques, increasing awareness among the people and increasing healthcare expenditure. Moreover, increasing geriatric population, and introducing new & advanced diagnostic options to cure gallbladder problems have fuelled the market growth

The Gallbladder Treatment Market is projected to reach USD 28,563.7 Million by 2030 at 8.3% CAGR during the forecast period 2022-2030.

Taste the market data and market information presented through more than 120 market data tables and figures spread over 125 pages of the project report. Avail the in-depth table of content TOC & market synopsis on “gall bladder treatment market research report–Global forecast to 2023.”

Major players in gall bladder treatment market:

There are plenty of large and small market players which operate in this market: Boston Scientific Corporation, Intuitive Surgical, C. R. Bard, Inc., Dornier MedTech, Koninklijke Philips N.V., B. Braun Melsungen AG, Sanofi and others

Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of Gallbladder Treatment Market Research Report

Regional Analysis:

Considering the global scenario of the gall bladder treatment market, there are four main regions: America, Europe, Asia Pacific, and the Middle East & Africa.

America accounts for the largest market owing to the presence of huge patient population suffering from gall bladder diseases. A well-developed healthcare sector and high healthcare spending has also provided a push for the growth of the market.  America consists of two regions namely, North America and South America. North America is the major market share holder.

Europe holds the second largest market share in global gall bladder treatment market. Some major factors that attribute the growth of Europe gall bladder treatment market is, increasing government support for researched development. Germany, France and UK are the major contributor in the Europe gall bladder treatment market.

Asia Pacific is the fastest growing market. Improving healthcare infrastructure, presence of huge patient population, rising awareness about gall bladder treatment has driven the growth for this market in Asia Pacific. However, the Middle East & Africa accounts for the lowest share in the global gall bladder treatment market.

Segmentation:

Global gall bladder treatment market has been segmented on the basis of disease indications, diagnosis, treatment and end users. On the basis of disease indications the market is segmented as gallstones, cholecystitis & biliary colic, cholelithiasis & choledocholithiasis, gallbladder polyps, gall bladder cancer. On the basis of diagnosis the market is categorized as ultrasound, blood tests, computerized tomography (CT), cholangiography and hepatobiliary scintigraphy and others. On the basis of treatment the market is segmented into surgery, and drugs and on the basis of end users the market is divided into hospitals & gynecology clinics, academic & research centers and others.